Prices – Vaudreuil

Between the 11^th and 14 ^th week

Risk calculation based on serum markers, maternal factors and ultrasound measurments.

Detects

• The main trisomies (18 and 21)

Screens up to 98% of cases of trisomy 21

Nuchal translucency ultrasound necessary

Results within 3 to 5 business days, analyzed in Quebec

Access to fetal DNA screening free of charge in cases of high risk of trisomy 21 >1/2500 or high risk of trisomy 18.

Possible options :

• Serum marker screening (nuchal translucency ultrasound performed at another facility) $375
• Serum marker screening with Prenato nuchal translucency: $510
• Serum marker screening with fetal sex: $499
• Serum marker screening with fetal sex and Prenato nuchal translucency: $675

As early as from the 10 ^th week

Blood test

Analysis of the fetal DNA from the maternal blood test.

Detects

Trisomy chromosomes 13, 18 and 21

Fetal gender

Reliability up to 99.9%

Results between 3 to 5 working days of laboratory analysis

Nuchal translucency ultrasound not included

Available options

• + $ 50: Sex chromosome aneuploidies (+fetal sex)
• + $ 100: Microdeletions* with or without sex chromosome aneuploidies (+fetal sex)
• + $ 100: All trisomies (all 23 pairs of chromosomes) and sex chromosome aneuploides (+fetal sex)
• + $ 150 : All trisomies (all 23 pairs of chromosomes), sex chromosome aneuploidies (+fetal sex) and microdeletions *
  • * 22q11.2 deletion (DiGeorge)
  • *15q11.2 (Angelman / Prader-Willi)
  • *1p36 deletion
  • *4p- (Wolf-Hirschhorn)
  • *5p- (Cri-du-chat)

Available as an option with the purchase of a prenatal screening test and a nuchal translucency ultrasound.

Between the 11^th and 13 ^th week

Blood test
Based on serum, ultrasound and maternal markers

Reliability up to 90%

Allows the prevention of pre-term preeclampsia (before 36 weeks of pregnancy)